Insider trades
John Aballi, CEO of Exagen XGN, has filed 2 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $473.8K. The latest trade was on 03/12.
John Aballi
President and CEO
- Company
- Exagen XGN
- First filing
- 23/09/06
- Trades
- 15 trades
- Buys / sales
- 2 / 4
- 12-month net buying
- −$473.8K
- Last trade
- 03/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ExagenXGN | Open-market sale | 03/03 | 03/04 | 15,698 sh | $3.62 | $56,826.76 | −2.2% |
ExagenXGN | Open-market sale | 02/24 | 02/25 | 11,430 sh | $3.61 | $41,262.3 | −1.6% |
ExagenXGN | Open-market sale | 25/10/16 | 25/10/20 | 31,787 sh | $11.82 | $375,722.34 | −4.3% |
ExagenXGN | Open-market buy | 24/11/14 | 24/11/18 | 24,305 sh | $2.81 | $68,297.05 | +3.7% |
ExagenXGN | Open-market buy | 24/05/16 | 24/05/16 | 40,401 sh | $1.92 | $77,569.92 | No record |
ExagenXGN | Open-market sale | 23/10/17 | 23/10/18 | 33,819 sh | $1.75 | $59,183.25 | −7.5% |